36462 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Oct 20
00:22 UTC
|
CGX
Cineplex
|
◎ Target | firm only | Hold | C$11.50→ C$12.25+6.5% |
|
Oct 20
00:22 UTC
|
CG
Carlyle Group
|
◎ Target | Crispin Love ★★★☆☆ #1563 | Overweight | $54.00→ $48.00-11.1% |
|
Oct 20
00:22 UTC
|
CFG
Citizens Financial Group
|
◎ Target | Gerard Cassidy ★★★★☆ #612 | Outperform | $79.00→ $74.00-6.3% |
|
Oct 20
00:22 UTC
|
CFG
Citizens Financial Group
|
◎ Target | Manan Gosalia ★★★☆☆ #1098 | Overweight | $89.00→ $87.00-2.2% |
|
Oct 20
00:22 UTC
|
CDNA
CareDx
|
◎ Target | Kyle Mikson not yet tracked | Buy | $65.00→ $80.00+23.1% |
|
Oct 20
00:22 UTC
|
CCK
Crown
|
◎ Target | Richard Carlson not yet tracked | Equal Weight | $127.00→ $126.00-0.8% |
|
Oct 20
00:22 UTC
|
CCJ
Cameco
|
◎ Target | Richard Garchitorena ★★★☆☆ #1673 | Equal Weight | $97.00→ $95.00-2.1% |
|
Oct 20
00:22 UTC
|
CAI
Caris Life Sciences
|
◎ Target | Kyle Mikson not yet tracked | Hold | $22.00→ $30.00+36.4% |
|
Oct 20
00:22 UTC
|
BYD
Boyd Gaming
|
◎ Target | Trey Bowers ★★★☆☆ #1799 | Equal Weight | $87.00→ $86.00-1.1% |
|
Oct 20
00:22 UTC
|
BX
Blackstone
|
◎ Target | Crispin Love ★★★☆☆ #1563 | Neutral | $130.00→ $125.00-3.8% |
|
Oct 20
00:22 UTC
|
BNY
Bank of New York Mellon
|
◎ Target | Benjamin Gerlinger not yet tracked | Neutral | $160.00→ $157.00-1.9% |
|
Oct 20
00:22 UTC
|
BMI
Badger Meter
|
◎ Target | Nathan Jones ★★★☆☆ #1905 | Buy | $165.00→ $150.00-9.1% |
|
Oct 20
00:22 UTC
|
BLK
BlackRock
|
◎ Target | James Fotheringham not yet tracked | Outperform | $1,300.00→ $1,350.00+3.8% |
|
Oct 20
00:22 UTC
|
BKS
Beeks Financial Cloud Group
|
◎ Target | firm only | Buy | GBX 335→ GBX 300-10.4% |
|
Oct 20
00:22 UTC
|
BKR
Baker Hughes
|
◎ Target | Scott Gruber ★★★☆☆ #1735 | Buy | $75.00→ $72.00-4.0% |
|
Oct 20
00:22 UTC
|
BEPC
Brookfield Renewable
|
◎ Target | Mark Strouse ★☆☆☆☆ #3009 | Neutral | $36.00→ $32.00-11.1% |
|
Oct 20
00:22 UTC
|
BEP
Brookfield Renewable Partners
|
◎ Target | Mark Strouse ★☆☆☆☆ #3009 | Neutral | $36.00→ $32.00-11.1% |
|
Oct 20
00:22 UTC
|
BBIO
BridgeBio Pharma
|
◎ Target | Biren Amin ★☆☆☆☆ #3125 | Overweight | $115.00→ $120.00+4.3% |
|
Oct 20
00:22 UTC
|
BBIO
BridgeBio Pharma
|
◎ Target | Eric Joseph ★★★☆☆ #1846 | Neutral | $94.00→ $91.00-3.2% |
|
Oct 20
00:22 UTC
|
BALL
Ball
|
◎ Target | Richard Carlson not yet tracked | Overweight | $72.00→ $70.00-2.8% |
|
Oct 20
00:22 UTC
|
AWK
American Water Works
|
◎ Target | Nicholas Campanella ★★★☆☆ #2240 | Underweight | $130.00→ $127.00-2.3% |
|
Oct 20
00:22 UTC
|
AVAV
AeroVironment
|
◎ Target | Trevor Walsh not yet tracked | Market Outperform | $230.00→ $170.00-26.1% |
|
Oct 20
00:22 UTC
|
ARQT
Arcutis Biotherapeutics
|
◎ Target | Seamus Fernandez ★★★☆☆ #2016 | Buy | $38.00→ $44.00+15.8% |
|
Oct 20
00:22 UTC
|
ARES
Ares Management
|
◎ Target | Crispin Love ★★★☆☆ #1563 | Overweight | $150.00→ $143.00-4.7% |
|
Oct 20
00:22 UTC
|
APP
AppLovin
|
◎ Target | Jason Bazinet ★★☆☆☆ #2712 | Buy | $600.00→ $500.00-16.7% |
|
Oct 20
00:22 UTC
|
APO
Apollo Global Management
|
◎ Target | Crispin Love ★★★☆☆ #1563 | Overweight | $159.00→ $145.00-8.8% |
|
Oct 20
00:22 UTC
|
ANRO
Alto Neuroscience
|
◎ Target | Patrick R. Trucchio not yet tracked | Buy | $55.00→ $60.00+9.1% |
|
Oct 20
00:22 UTC
|
AMRZ
Amrize
|
◎ Target | Adam Seiden ★★★☆☆ #1699 | Equal Weight | $55.00→ $40.00-27.3% |
|
Oct 20
00:22 UTC
|
AMH
American Homes 4 Rent
|
◎ Target | James Feldman ★★★☆☆ #1881 | Overweight | $38.00→ $34.00-10.5% |
|
Oct 20
00:22 UTC
|
AGCO
AGCO
|
◎ Target | Adam Seiden ★★★☆☆ #1699 | Underweight | $105.00→ $97.00-7.6% |
|
Oct 20
00:22 UTC
|
AEP
American Electric Power
|
◎ Target | Jeremy Tonet ★★★☆☆ #1898 | Neutral | $140.00→ $135.00-3.6% |
|
Oct 20
00:22 UTC
|
AEP
American Electric Power
|
◎ Target | James Thalacker ★★★☆☆ #1744 | Market Perform | $139.00→ $135.00-2.9% |
|
Oct 20
00:22 UTC
|
AEM
Agnico Eagle Mines
|
◎ Target | Richard Garchitorena ★★★☆☆ #1673 | Overweight | $188.00→ $218.00+16.0% |
|
Oct 20
00:22 UTC
|
AEE
Ameren
|
◎ Target | Nicholas Campanella ★★★☆☆ #2240 | Equal Weight | $117.00→ $109.00-6.8% |
|
Oct 20
00:22 UTC
|
ADNT
Adient
|
◎ Target | Nathan Janes not yet tracked | Buy | $26.00→ $21.00-19.2% |
|
Oct 20
00:22 UTC
|
ADC
Agree Realty
|
◎ Target | James Feldman ★★★☆☆ #1881 | Overweight | $83.00→ $79.00-4.8% |
|
Oct 20
00:22 UTC
|
ABX
Barrick Gold
|
◎ Target | firm only | Buy | C$90.00→ C$84.00-6.7% |
|
Oct 20
00:22 UTC
|
ABX
Abacus Global Management
|
◎ Target | Crispin Love ★★★☆☆ #1563 | Neutral | $12.00→ $10.00-16.7% |
|
Oct 20
00:22 UTC
|
AARD
Aardvark Therapeutics
|
◎ Target | Raghuram Selvaraju not yet tracked | Neutral | $6.00→ $4.00-33.3% |
|
Oct 19
23:22 UTC
|
ETOR
eToro Group
|
◎ Target | Joseph Vafi ★☆☆☆☆ #3097 | Buy | $53.00→ $47.00-11.3% |
|
Oct 19
23:22 UTC
|
DX
Dynex Capital
|
◎ Target | Jason Weaver ★☆☆☆☆ #2937 | Buy | $14.75→ $12.50-15.3% |
|
Oct 19
22:22 UTC
|
SLB
SLB
|
◎ Target | Scott Gruber ★★★☆☆ #1735 | Buy | $63.00→ $62.00-1.6% |
|
Oct 19
22:22 UTC
|
PNC
The PNC Financial Services Group
|
◎ Target | Benjamin Gerlinger not yet tracked | Buy | $290.00→ $270.00-6.9% |
|
Oct 19
22:22 UTC
|
PII
Polaris
|
◎ Target | James Hardiman ★★☆☆☆ #2466 | Neutral | $67.00→ $56.00-16.4% |
|
Oct 19
22:22 UTC
|
OVV
Ovintiv
|
◎ Target | Kevin Fisk ★★★★★ #167 | Sec→ r Outperform | $75.00→ $80.00+6.7% |
|
Oct 19
22:22 UTC
|
FMC
FMC
|
◎ Target | Patrick Cunningham ★★★☆☆ #2025 | Neutral | $12.00→ $6.00-50.0% |
|
Oct 19
22:22 UTC
|
CRI
Carter's
|
◎ Target | Jay Sole ★★★☆☆ #2032 | Neutral | $41.00→ $38.00-7.3% |
|
Oct 19
21:22 UTC
|
XYL
Xylem
|
◎ Target | Mark Strouse ★☆☆☆☆ #3009 | Neutral | $137.00→ $118.00-13.9% |
|
Oct 19
21:22 UTC
|
WFRD
Weatherford International
|
◎ Target | Scott Gruber ★★★☆☆ #1735 | Buy | $115.00→ $112.00-2.6% |
|
Oct 19
21:22 UTC
|
SHLS
Shoals Technologies Group
|
◎ Target | Mark Strouse ★☆☆☆☆ #3009 | Overweight | $13.00→ $12.00-7.7% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.